May 2011 Issue of MMM

May 2011 Issue of MMM

May 2011

Editor's Desk

The incredible thinking industry

In Jack Arnold's 1957 cult sci-fi classic The Incredible Shrinking Man, businessman Robert Scott Carey is condemned to a life of shrinkage, for which there ...

Features

Pharma Report: Cliff Notes

Drug revenues barely kept pace last year, as other indicators like numbers of protected brands and reps have decreased, amid the overall trend of industry ...

Medical Education: Transparency Trap

Pharma is spending millions to prepare for the Sunshine Act. But with disclosure likely to drive negative press, drug firms should consider changing the way ...

Online Privacy: Right Side of the Tracks

Digital marketing of healthcare products is under assault. Pharma must up transparency and educate the public about the robust consumer privacy safeguards in place, writes ...

MM&M Awards 2011: Who Are They to Judge?

The MM&M Awards 2011 judging panel is in place and poised to descend on the Hotel Warwick in New York City on June 27 for ...

Headliner: Genentech's Ian Clark

Ian Clark, Genentech's CEO and head of North American commercial operations, is this year's Healthcare Businesswomen's Association (HBA) Honorable Mentor

Antidote

Antidote: generic drugs

Use of generic drugs has grown dramatically in the US, to the point where currently almost 75% of the drugs we use are generic.

In Focus

Will healthcare reform gains outweigh pain?

The Patient Protection and Affordable Care Act turned one in March, and it was, for the drug industry, an ambivalent occasion.

Professional Marketing

Pharma-free residencies up: survey

Most US family medicine resident programs have limits on drug industry interaction with doctors, and a quarter shun doctor-company contacts altogether, said a survey by ...

Doctors value details, says PhRMA-sponsored survey

A PhRMA-sponsored survey found that nearly eight in 10 US physicians see drug companies and their sales reps as useful sources of information on prescription ...

Professional Marketing briefs

Featuring news about Physicians Interactive Holdings, Challenger Gray & Christmas, and GlaxoSmithKline

Med Ed Report

ACC nixes satellite-symposia model

In a move aimed at better educating its members and reducing confusion between independent, CME-certified medical education and non-independent promotional events, the American College of ...

Interest in branded programs wanes

Interest in attending sponsored speaker programs in a traditional dinner program format is waning, says medical meetings producer Pri-Med.

Society rejects CMSS COI code

The American Rhinologic Society (ARS) adopted a COI policy that permits transparent interactions between industry and ARS and its leadership.

Med Ed Report briefs

Featuring news about Unbound Medicine, Publicis Touchpoint Solutions, Elsevier, Cleveland Clinic and Vindico Medical Education

Professional Media

Global docs prefer live reps to digital channels

For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from ...

Novartis reviews media: report

Novartis is launching a global media review, reported Advertising Age.

Professional Media briefs

Featuring news about Sermo, Janssen Global Services, Henry Schein Inc. and Wolters Kluwer Pharma Solutions

Partner Forum

How do CPG alliances aid pharmas?

Teva's alliance with P&G should enable the drugmaker to get competitive rates on global media buys for its OTC products. Are there other opportunities for ...

Digital Media

Google adds Facebook-like +1 to ads

Google is making its ads interactive with a "+1" button that will basically allow users to "like" ads and recommend them to their friends.

Social networkers want pharmas in the conversation: poll

Social media "power users" who value interaction with healthcare companies want them regulated but around, according to a WEGO Health survey.

Digital Media briefs

Featuring news about Capstrat-Public Policy Polling, American Medical Association and Good Health Media

Consumer Marketing

DDR on DTC: RAPAFLO

BPH is one of those conditions that affects a large population and has physical symptomology that makes sufferers very uncomfortable.

BI recruits Seymour for stroke awareness effort

Boehringer Ingelheim has recruited actress Jane Seymour to serve as the face of a continental European atrial fibrillation and stroke awareness campaign.

UK gets social media presence

The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued "informal guidance" on digital communications, and while it's more than ...

Marketing Research

Vantage Point

Understanding and measuring what motivates behavior is a central goal for many pharmaceutical market research projects.

Marketing researchers spread thin, data show

Data indicate a noticeable step-up in the workload for market research pros based at pharmaceutical firms.

New recruits expand Ipsos Health

Ipsos Health hired nine researchers to support North American operations, including seven US- and two Canada-based staffers.

Agency Business

Havas launches '#a11y' digital practice

Havas Drive has launched a practice focused on developing digital products for persons with disabilities and those undergoing rehabilitative therapies.

inVentiv's GSW launches health and wellness practice

InVentiv's GSW is going after the consumer health and wellness market with an offshoot, dubbed The Well @ GSW, aimed at OTC brands, consumer products ...

Agency Business briefs

Featuring news about Cadient, GCI Health, Biocell Center and Allison & Partners

Washington Insider

As I see it

There's a generational element to the failure of the Obama administration's much-hyped agenda to increase transparency at government agencies like FDA, where reform has been ...

Forest to pay $164M for various violations

A federal judge has sentenced Forest Pharmaceuticals to pay a criminal fine of $150 million and forfeit $14 million in assets for its guilty plea ...

FDA tightens fast-track approval regs

FDA says it plans to fine companies up to $10 million who lack "due diligence" in completing confirmatory trials for drugs granted accelerated approval.

Viewpoint

Five secrets for great mobile health advertising

The mobile advertising platform is a unique environment.

Back Talk

Moms on the front line

On Feb. 28, more than 30 countries across the world observed Rare Disease Day.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.